30 F.4th 189
4th Cir.2022Background
- Defendant Terrell Hargrove, serving a 103-month federal sentence (46 months for drug trafficking + 57 months for supervised-release revocation), moved for compassionate release under 18 U.S.C. § 3582(c)(1)(A)(i) in July 2020 citing COVID-19 outbreaks at his facilities.
- Hargrove reported medical conditions: asthma, obstructive sleep apnea, and elevated blood-pressure readings (no formal hypertension diagnosis); he claimed these made severe COVID-19 complications reasonably probable.
- He also emphasized clean disciplinary record in current term, completion of programming, a concrete release plan, and family support.
- The district court denied relief, reasoning that Hargrove showed only that his conditions might increase risk (not an extraordinary and compelling reason) and that the § 3553(a) factors weighed against release.
- On appeal Hargrove argued the district court (1) applied a forbidden bright-line CDC-based rule, (2) improperly considered § 3553(a)(2)(A) retributive factors despite a revocation component, and (3) failed to credit or explain rejection of his rehabilitation efforts.
- The Fourth Circuit affirmed, concluding the district court did not adopt a bright-line rule, properly considered § 3553(a) factors, and adequately addressed rehabilitation in its balancing.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether the district court applied a bright-line rule excluding conditions not in CDC highest-risk category | Hargrove: court limited consideration to CDC highest-tier risks and thus erred | Government/district court: court used CDC guidance as evidence and found Hargrove showed only a possible (not particularized) susceptibility | Court: did not apply a bright-line rule and did not abuse discretion; evidence failed to show extraordinary and compelling reasons |
| Whether retributive § 3553(a)(2)(A) factors may be considered given part of the sentence is a revocation sentence | Hargrove: retributive factors are barred when imposing revocation sentences and thus should not be used to deny reduction of that portion | Government: compassionate-release review must consider § 3553(a) to the extent applicable; Congress distinguished imposing a revocation sentence from reducing an imposed sentence | Court: § 3553(a) factors were properly considered; different statutory contexts allow consideration when deciding a reduction |
| Whether the district court failed to consider or explain the weight given to Hargrove's rehabilitation | Hargrove: court did not address his post-sentencing rehabilitation or explain why it was discounted | Government/district court: judge acknowledged and commended rehabilitation but found it did not outweigh the reasons supporting the original sentence; judge had sentenced Hargrove previously and considered history | Court: explanation was sufficient for meaningful review; rehabilitation was considered but did not overcome the § 3553(a) balance |
Key Cases Cited
- United States v. McCoy, 981 F.3d 271 (4th Cir. 2020) (guidance that § 1B1.13 is not an applicable policy statement for prisoner-filed motions but remains useful)
- United States v. High, 997 F.3d 181 (4th Cir. 2021) (district court must consider § 3553(a) factors after finding extraordinary and compelling reasons)
- United States v. Kibble, 992 F.3d 326 (4th Cir. 2021) (standard of review for compassionate-release denials: abuse of discretion)
- Dillon v. United States, 560 U.S. 817 (2010) (distinguishing imposing a sentence from later reducing it)
- Chavez-Meza v. United States, 138 S. Ct. 1959 (2018) (appellate review requires district court to set forth enough to show it considered arguments and provide reasoned basis)
- United States v. Harris, 989 F.3d 908 (11th Cir. 2021) (affirming that conditions listed by CDC as possibly increasing risk may nonetheless be insufficient in specific cases)
- United States v. Thompson, 984 F.3d 431 (5th Cir. 2021) (district court not abusive in concluding well-controlled chronic conditions did not show significantly higher risk)
